Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

Bavarian Nordic

Ylin-
Alin-
Vaihto-
2026 Q2 - tulosraportti
34 päivää sitten

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Rahastot ja ETF:t, joilla on osaketta

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 Q3 - tulosraportti
13.11.
Menneet tapahtumat
2026 Q2 - tulosraportti
21.8.
2026 Q1 - tulosraportti
13.5.
2025 Q4 - tulosraportti
12.3.
2025 Q3 - tulosraportti
14.11.2025
2025 Q2 - tulosraportti
22.8.2025

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 21 t sitten
    ·
    Interesting how long the positive price development can last, when the company is fundamentally unchanged. It is usually only on borrowed time.
    15 t sitten
    ·
    Progression...think you are a bit off base when it comes to BAVA. Have you misjudged the stock, or what is happening? When I look at my biotech stocks, BAVA has done the best this year.
  • 17.9.
    ·
    New CEO - take off ! - She looks like a strong card ! - https://www.euroinvestor.dk/nyheder/bavarian-nordic-udpeger-ny-topchef
    1 päivä sitten
    ·
    BN is slowly but surely climbing the price ladder. Good to see 💪
  • 17.9. · Muokattu
    ·
    I thought it fell almost 10 % in usa? Was it due to the choice of the new boss?
    17.9.
    ·
    followed the stock price on Webull where I track my American stocks, it fell 9.82%
  • 11.9. · Muokattu
    ·
    The core assortment is gradually selling really well and all key figures are continuously improving. All the "peripheral" stuff fluctuates a bit but the American initiative is another step in the right direction. I think a new CEO will provide an excuse for take-off even though the business is already running extremely well. But it took some time to clear out all the cobwebs and peculiar projects. But .. here we go ! I have continuously added to a now good position and am just looking forward to "more".
    14.9.
    ·
    Yes, that is actually one of the stocks I have earned the most on, by selling and buying, over, perhaps twenty years.
  • 10.9.
    ·
    While the market is buzzing about today's small fluctuations, I'm sitting here looking at the numbers for Bavarian Nordic. The dip we're seeing right now towards 202–205 kr.? It looks like a definite bargain: Insane valuation: A P/E of around 10 for a profitable business that rakes in 1.24 billion kr. in free cash flow. They're earning real, cold cash – day after day. Massive share buyback: Management is spending up to 750 million kr. to buy back its own shares. This sucks shares out of the market and makes each of our holdings more valuable. Growth is in full swing: Raised guidance for 2026, and the approval of the mpox vaccine for children opens the door for significantly larger sales. Technical treat: The price is currently testing the 20-day average (203–206 kr.). It's a straight pullback with one of the absolute best risk/reward ratios in the Danish index right now. Finding a self-financing growth company on C25 that both makes large share buybacks and trades at a bargain price almost never happens. I'm buying up!
    11.9.
    ·
    I agree that it generally looks positive. My current concerns, however, include the following: - Lower trading volume due to lost C25 status. - Ongoing management change, where we only know what we are saying goodbye to, but not what we are getting. - A potential inherent historical psychology among owners and speculators, which means the share price will not necessarily develop as expected based on the key figures, no matter how rosy the picture may appear. I must honestly concur with the latter issue and admit that I almost always expect BAVA to fall a little more, because that is how the stock has been perceived for a very long time. And the latest decline has actually only strengthened that expectation.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

Välittäjätilasto

Dataa ei löytynyt
2026 Q2 - tulosraportti
34 päivää sitten

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 21 t sitten
    ·
    Interesting how long the positive price development can last, when the company is fundamentally unchanged. It is usually only on borrowed time.
    15 t sitten
    ·
    Progression...think you are a bit off base when it comes to BAVA. Have you misjudged the stock, or what is happening? When I look at my biotech stocks, BAVA has done the best this year.
  • 17.9.
    ·
    New CEO - take off ! - She looks like a strong card ! - https://www.euroinvestor.dk/nyheder/bavarian-nordic-udpeger-ny-topchef
    1 päivä sitten
    ·
    BN is slowly but surely climbing the price ladder. Good to see 💪
  • 17.9. · Muokattu
    ·
    I thought it fell almost 10 % in usa? Was it due to the choice of the new boss?
    17.9.
    ·
    followed the stock price on Webull where I track my American stocks, it fell 9.82%
  • 11.9. · Muokattu
    ·
    The core assortment is gradually selling really well and all key figures are continuously improving. All the "peripheral" stuff fluctuates a bit but the American initiative is another step in the right direction. I think a new CEO will provide an excuse for take-off even though the business is already running extremely well. But it took some time to clear out all the cobwebs and peculiar projects. But .. here we go ! I have continuously added to a now good position and am just looking forward to "more".
    14.9.
    ·
    Yes, that is actually one of the stocks I have earned the most on, by selling and buying, over, perhaps twenty years.
  • 10.9.
    ·
    While the market is buzzing about today's small fluctuations, I'm sitting here looking at the numbers for Bavarian Nordic. The dip we're seeing right now towards 202–205 kr.? It looks like a definite bargain: Insane valuation: A P/E of around 10 for a profitable business that rakes in 1.24 billion kr. in free cash flow. They're earning real, cold cash – day after day. Massive share buyback: Management is spending up to 750 million kr. to buy back its own shares. This sucks shares out of the market and makes each of our holdings more valuable. Growth is in full swing: Raised guidance for 2026, and the approval of the mpox vaccine for children opens the door for significantly larger sales. Technical treat: The price is currently testing the 20-day average (203–206 kr.). It's a straight pullback with one of the absolute best risk/reward ratios in the Danish index right now. Finding a self-financing growth company on C25 that both makes large share buybacks and trades at a bargain price almost never happens. I'm buying up!
    11.9.
    ·
    I agree that it generally looks positive. My current concerns, however, include the following: - Lower trading volume due to lost C25 status. - Ongoing management change, where we only know what we are saying goodbye to, but not what we are getting. - A potential inherent historical psychology among owners and speculators, which means the share price will not necessarily develop as expected based on the key figures, no matter how rosy the picture may appear. I must honestly concur with the latter issue and admit that I almost always expect BAVA to fall a little more, because that is how the stock has been perceived for a very long time. And the latest decline has actually only strengthened that expectation.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Rahastot ja ETF:t, joilla on osaketta

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 Q3 - tulosraportti
13.11.
Menneet tapahtumat
2026 Q2 - tulosraportti
21.8.
2026 Q1 - tulosraportti
13.5.
2025 Q4 - tulosraportti
12.3.
2025 Q3 - tulosraportti
14.11.2025
2025 Q2 - tulosraportti
22.8.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

Välittäjätilasto

Dataa ei löytynyt
2026 Q2 - tulosraportti
34 päivää sitten

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 Q3 - tulosraportti
13.11.
Menneet tapahtumat
2026 Q2 - tulosraportti
21.8.
2026 Q1 - tulosraportti
13.5.
2025 Q4 - tulosraportti
12.3.
2025 Q3 - tulosraportti
14.11.2025
2025 Q2 - tulosraportti
22.8.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 21 t sitten
    ·
    Interesting how long the positive price development can last, when the company is fundamentally unchanged. It is usually only on borrowed time.
    15 t sitten
    ·
    Progression...think you are a bit off base when it comes to BAVA. Have you misjudged the stock, or what is happening? When I look at my biotech stocks, BAVA has done the best this year.
  • 17.9.
    ·
    New CEO - take off ! - She looks like a strong card ! - https://www.euroinvestor.dk/nyheder/bavarian-nordic-udpeger-ny-topchef
    1 päivä sitten
    ·
    BN is slowly but surely climbing the price ladder. Good to see 💪
  • 17.9. · Muokattu
    ·
    I thought it fell almost 10 % in usa? Was it due to the choice of the new boss?
    17.9.
    ·
    followed the stock price on Webull where I track my American stocks, it fell 9.82%
  • 11.9. · Muokattu
    ·
    The core assortment is gradually selling really well and all key figures are continuously improving. All the "peripheral" stuff fluctuates a bit but the American initiative is another step in the right direction. I think a new CEO will provide an excuse for take-off even though the business is already running extremely well. But it took some time to clear out all the cobwebs and peculiar projects. But .. here we go ! I have continuously added to a now good position and am just looking forward to "more".
    14.9.
    ·
    Yes, that is actually one of the stocks I have earned the most on, by selling and buying, over, perhaps twenty years.
  • 10.9.
    ·
    While the market is buzzing about today's small fluctuations, I'm sitting here looking at the numbers for Bavarian Nordic. The dip we're seeing right now towards 202–205 kr.? It looks like a definite bargain: Insane valuation: A P/E of around 10 for a profitable business that rakes in 1.24 billion kr. in free cash flow. They're earning real, cold cash – day after day. Massive share buyback: Management is spending up to 750 million kr. to buy back its own shares. This sucks shares out of the market and makes each of our holdings more valuable. Growth is in full swing: Raised guidance for 2026, and the approval of the mpox vaccine for children opens the door for significantly larger sales. Technical treat: The price is currently testing the 20-day average (203–206 kr.). It's a straight pullback with one of the absolute best risk/reward ratios in the Danish index right now. Finding a self-financing growth company on C25 that both makes large share buybacks and trades at a bargain price almost never happens. I'm buying up!
    11.9.
    ·
    I agree that it generally looks positive. My current concerns, however, include the following: - Lower trading volume due to lost C25 status. - Ongoing management change, where we only know what we are saying goodbye to, but not what we are getting. - A potential inherent historical psychology among owners and speculators, which means the share price will not necessarily develop as expected based on the key figures, no matter how rosy the picture may appear. I must honestly concur with the latter issue and admit that I almost always expect BAVA to fall a little more, because that is how the stock has been perceived for a very long time. And the latest decline has actually only strengthened that expectation.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Rahastot ja ETF:t, joilla on osaketta

Välittäjätilasto

Dataa ei löytynyt